2017 Archived Content


Monday, April 24 | 6:00 - 9:00 pm

SC1: A New Era in Patient Recruitment: Understanding Social and Digital Media’s Power to Accelerate Your Clinical Trial

Mastering the process of finding, engaging and activating patients for enrollment into a clinical trial is a key success factor for all biopharmaceutical companies developing new treatments. Patients have transitioned online to seek disease, drug and clinical trial information. Thus, if our industry is looking to intersect with patients for clinical trials, social media cannot be overlooked. In fact, social media for clinical trials must become a basic component of every clinical trial recruitment plan. This course will provide the participants with an advanced understanding of how to use social and digital technologies to master patient engagement and accelerate drug development.


Sandra Shpilberg, CEO, Seeker Health

Detailed Agenda

SC3: Mobile Health and Virtual Studies: How to Accelerate Their Use and Adoption in Your Company

This workshop will explore how mobile health and virtual research studies are being conducted in pharma-focused programs with input from industry leaders on the market, lessons learned, data standards, privacy, platforms in use, adoption strategies and much more on the topic. This session will be interactive with short burst 15 minute presentations that lead to breakout groups for focus on specific topics of interest in small groups. After the discussion, there will be readouts from each group and open discussion and Q&A with all in attendance.


John Reites, Chief Product Officer and Partner, THREAD

Joe Dustin, Director, Mobile Health, Medidata

Spyros Papapetropoulos, Vice President & Global Head, Clinical Development, Movement Disorders & Neurodegenerative Diseases, Teva

Detailed Agenda

*Separate registration required.

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag


From the Producers of:

From the Producers of SCOPE